Ignite Creation Date:
2025-12-24 @ 2:32 PM
Ignite Modification Date:
2025-12-27 @ 3:21 PM
Study NCT ID:
NCT05004259
Status:
COMPLETED
Last Update Posted:
2025-03-30
First Post:
2021-07-28
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
The Safety of Repurposing Daratumumab for Relapsed or Refractory Autoimmune Antibody Mediated Hemolytic Anemia
Sponsor:
Dartmouth-Hitchcock Medical Center
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
STUDY02000992 21SUL992
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None